Difference between revisions of "Montelukast (Singulair)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
| Line 6: | Line 6: | ||
[[Category:Antileukotrienes]] | [[Category:Antileukotrienes]] | ||
| − | [[Category: | + | [[Category:FDA approved in 2003]] |
Revision as of 19:17, 30 July 2018
Sometimes used in hypersensitivity protocols or as a premedication for antineoplastics highly likely to provoke and allergic reaction. Also used as a preventative medication for mast cell diseases.